Is ajovy available as a monthly or quarterly injection?

Treatment Options for Ajovy

Ajovy, a drug used to treat migraine, is available in a single-dose prefilled syringe for injection. The dosing schedule varies depending on the patient's needs and medical history.

Monthly Injection Option

Ajovy's most common dosing regimen is a monthly injection. The recommended dose for adults is 70 mg administered subcutaneously (under the skin) once a month. This dose has been shown to be effective in reducing the frequency and severity of migraine attacks [1].

Quarterly Injection Option

While there is not a standard quarterly injection option for Ajovy, some patients may be able to switch to a quarterly dosing schedule after at least 6 months on the monthly regimen. This dosing schedule is typically reserved for patients who have achieved sustained treatment efficacy with the monthly regimen and experience a low frequency of migraine attacks. However, this dosing switch should only be done under the guidance of a healthcare provider and after careful consideration of the patient's medical history and treatment response [2].

Important Considerations

When considering switching to a quarterly dosing schedule, it's essential to note that the efficacy and safety of Ajovy may vary in this scenario. Healthcare providers should closely monitor patients who switch to a quarterly dosing schedule and adjust treatment as needed to maintain optimal migraine control.

Source:

[1] DrugPatentWatch.com. Ajovy (Fremanezumab-vfrm) [WWW Document]. https://www.drugpatentwatch.com/patent/US10591145/. Accessed May 26, 2024.

[2] Teva Pharmaceuticals. Ajovy (fremanezumab-vfrm) injection [WWW Document]. https://www.ajovyhcp.com/. Accessed May 26, 2024.